- Pfizer, Beam Therapeutics Partner to Develop Treatments for 3 Genetic Diseases Barron’s
- Pfizer (PFE) to Pay $1.4 Billion to Partner With Beam to Develop Genetic Drugs Bloomberg
- Biotech Stocks: The Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer Investor’s Business Daily
- JP Morgan 2022 – Beam and Mammoth hook big pharma partners Vantage
- Pfizer Deepens Commitment to Genetic-Drug Future With Deals Bloomberg
- View Full coverage on Google News